Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | AHR | P35869 | 5/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 5/20 | 0.37 |
| ▸ | CA2 | P00918 | 5/20 | 0.37 |
| ▸ | CA9 | Q16790 | 4/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7289940 | 0.79 | CYP3A4 (0.59) | ALDH1A1CYP3A4AHRGAAMAPK1 | |
| SCHEMBL2593530 | 0.78 | CYP3A4 (0.56) | ALDH1A1CYP3A4AHRGAAMAPK1 | |
| SCHEMBL7279386 | 0.77 | DHFR (0.53) | — | |
| SCHEMBL5074455 | 0.77 | GAA (0.53) | ALDH1A1CYP3A4GAAMAPK1CA1 | |
| SCHEMBL7380268 | 0.73 | HSP90AA1 (0.41) | — | |
| SCHEMBL10620711 | 0.72 | ALDH1A1 (0.45) | ALDH1A1CYP3A4GAAMAPK1CA1 | |
| SCHEMBL9848562 | 0.72 | SCN9A (0.57) | MAPK1 | |
| SCHEMBL30034845 | 0.71 | CYP3A4 (0.67) | ALDH1A1CYP3A4AHRMAPK1TSHR | |
| SCHEMBL2230314 | 0.71 | CYP3A4 (0.67) | ALDH1A1CYP3A4AHRMAPK1TSHR | |
| SCHEMBL11687207 | 0.67 | ALDH1A1 (0.39) | ALDH1A1CYP3A4GAAMAPK1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260131280-A1 | GAS SEPARATION MEMBRANE UNIT, GAS SEPARATION SYSTEM, AND METHOD FOR PRODUCING ENRICHED GAS | UBE CORP (JP) | 2026-05-14 | — | — | US | disclosed |
| EP-4721843-A1 | GAS SEPARATION MEMBRANE UNIT, GAS SEPARATION SYSTEM, AND METHOD FOR PRODUCING ENRICHED GAS | UBE Corporation (JP) | 2026-04-08 | — | — | EP | disclosed |
| EP-4691603-A1 | GAS SEPARATION SYSTEM AND METHOD FOR PRODUCING METHANE ENRICHED GAS | UBE Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260008003-A1 | GAS SEPARATION SYSTEM AND METHOD FOR PRODUCING METHANE-ENRICHED GAS | UBE CORP (JP) | 2026-01-08 | — | — | US | disclosed |
| US-10765992-B2 | Gas separation membrane module and method for gas separation | UBE INDUSTRIES, LTD. (JP) | 2020-09-08 | — | — | US | disclosed |
| US-10369515-B2 | Gas separation membrane module and method for gas separation | UBE INDUSTRIES, LTD. (JP) | 2019-08-06 | — | — | US | disclosed |
| US-20190201839-A1 | GAS SEPARATION MEMBRANE MODULE AND METHOD FOR GAS SEPARATION | UBE CORPORATION (JP) | 2019-07-04 | — | — | US | disclosed |
| EP-2554248-B1 | ASYMMETRIC HOLLOW FIBER GAS SEPARATION MEMBRANE | UBE INDUSTRIES (JP) | 2019-02-20 | — | — | EP | disclosed |
| US-20180221812-A1 | GAS SEPARATION MEMBRANE MODULE AND METHOD FOR GAS SEPARATION | UBE CORPORATION (JP) | 2018-08-09 | — | — | US | disclosed |
| US-20180051172-A1 | CONDUCTIVE AROMATIC POLYIMIDE POROUS FILM AND METHOD FOR PRODUCING SAME | UBE INDUSTRIES, LTD. (JP) | 2018-02-22 | — | — | US | disclosed |
| US-8734568-B2 | Asymmetric hollow fiber gas separation membrane | UBE INDUSTRIES, LTD. (JP) | 2014-05-27 | — | — | US | disclosed |
| US-8580012-B2 | Solvent-resistant asymmetric hollow fiber gas separation membrane, and method for production thereof | UBE INDUSTRIES, LTD. (JP) | 2013-11-12 | — | — | US | disclosed |
| EP-2554248-A1 | ASYMMETRICAL HOLLOW FIBRE GAS SEPARATION MEMBRANE | Ube Industries, Ltd. (JP) | 2013-02-06 | — | — | EP | disclosed |
| US-20130019748-A1 | ASYMMETRIC HOLLOW FIBER GAS SEPARATION MEMBRANE | UBE INDUSTRIES, LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| US-20120304856-A1 | GAS SEPARATION MEMBRANE MODULE AND GAS SEPARATION METHOD | UBE INDUSTRIES, LTD. (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20110048229-A1 | SOLVENT-RESISTANT ASYMMETRIC HOLLOW FIBER GAS SEPARATION MEMBRANE, AND METHOD FOR PRODUCTION THEREOF | UBE INDUSTRIES, LTD. (JP) | 2011-03-03 | — | — | US | disclosed |
| EP-2239049-A1 | SOLVENT-RESISTANT ASYMMETRIC HOLLOW FIBER GAS SEPARATION MEMBRANE, AND METHOD FOR PRODUCTION THEREOF | Ube Industries, Ltd. (JP) | 2010-10-13 | — | — | EP | disclosed |
| US-7803214-B2 | Asymmetric hollow-fiber gas separation membrane, gas separation method and gas separation membrane module | UBE INDUSTRIES, LTD. (JP) | 2010-09-28 | — | — | US | disclosed |
| US-20080017029-A1 | Asymmetric hollow-fiber gas separation membrane, gas separation method and gas separation membrane module | UBE INDUSTRIES, LTD. (JP) | 2008-01-24 | — | — | US | disclosed |
| EP-0056475-A2 | Pharmaceutical compositions | MERCK PATENT GmbH (DE) | 1982-07-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260131280-A1 | GAS SEPARATION MEMBRANE UNIT, GAS SEPARATION SYSTEM, AND METHOD FOR PRODUCING ENRICHED GAS | SCO2, SLC2A4, STOML2 | ALDH1A1 4807/4885CYP3A4 1207/4885AHR 4591/4885 |
| US-20260008003-A1 | GAS SEPARATION SYSTEM AND METHOD FOR PRODUCING METHANE-ENRICHED GAS | SCO2, MT-CO2, SLC2A4 | ALDH1A1 4665/4885CYP3A4 435/4885AHR 4505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.